Gates Foundation

Activity from announced rounds

Activity in this selectionHealthtech
Rounds participated in
5
Confirmed lead rounds
0
4 roles undisclosed
New companies
5
First participation on record · 0 follow-on
Funding in participating rounds
$128.4M
3 disclosed · full round size, not this investor’s share

By stage

Undisclosed3
Series A1
Series B1

By primary sector

Biotech3
Healthtech2

By country

United States3
Netherlands1
Sweden1

Rounds

5 in this selection
Readily Diagnostics

Readily Diagnostics develops molecular tests that help clinicians identify infectious diseases near the patient without relying on a central laboratory.

~$970KGates Foundation grant
Participant
ProFound Therapeutics

Uses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia

$35MStrategic
Role not disclosed
Leyden Laboratories

Develops antibody-based nasal sprays intended to prevent influenza and other respiratory-virus infections.

€40MSeries B
Role not disclosed
Kanvas Biosciences

Develops microbiome-based live biotherapeutics for cancer patients who do not respond to immunotherapy

$48MSeries A
Role not disclosed
Qure.ai

Develops AI-powered diagnostic solutions for early detection and care management of diseases

Role not disclosed